Gemcitabine With or Without Pazopanib in Treating Patients With Refractory Soft Tissue Sarcoma

Clinical trial NCT01532687 · COMPLETED

Trial details

NCT number: NCT01532687
Sponsor: OHSU Knight Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Alveolar Soft Part Sarcoma Adult Angiosarcoma Adult Desmoplastic Small Round Cell Tumor Adult Epithelioid Hemangioendothelioma Adult Epithelioid Sarcoma Adult Extraskeletal Myxoid Chondrosarcoma Adult Extraskeletal Osteosarcoma Adult Fibrosarcoma Adult Leiomyosarcoma Adult Liposarcoma Adult Malignant Peripheral Nerve Sheath Tumor Adult Rhabdomyosarcoma

Start date: 2012-03-13
Primary completion: 2019-10-31
Enrollment: 54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.